Chan Henry Lee - Jun 15, 2023 Form 3 Insider Report for BeiGene, Ltd. (BGNE)

Role: SVP, General Counsel
Signature: /s/ Qing Nian, as Attorney-in-Fact
Stock symbol: BGNE
Transactions as of: Jun 15, 2023
Transactions value $: $0
Form type: 3
Date filed: 6/20/2023, 06:37 PM
Next filing: Aug 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BGNE	Ordinary Shares						116K	Jun 15, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BGNE	Share Option (Right to Buy)							Jun 15, 2023	Ordinary Shares	189K	$14.96	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares underlying unvested restricted share units. Unvested securities are subject to accelerated vesting upon certain termination events.
F2	These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.